New online platform to help pharmaceutical companies find, evaluate and manage drug partners

goBalto, an online drug development partnering site for the pharmaceutical development and drug manufacturing industry, announced today its new platform and website, goBalto.com. goBalto transforms the way drug-development partners are matched. The web-based platform enables members to quickly and efficiently find partners, share knowledge, and discover opportunities.

"U.S. and EU pharmaceutical companies are under pressure to reduce costs and boost efficiencies in the drug development process," said Jae Chung, founder & CEO, goBalto. "As a result, companies are increasingly looking towards outsourcing to help reduce costs. But it's challenging for companies to identify and evaluate drug service providers. goBalto is addressing this by creating an online resource where users can quickly find and evaluate drug service providers, resulting in improved transparency and better decision making."

goBalto incorporates the following key features for its members:

  • Search and browser tools to screen from more than 7,000 potential service providers (investigator sites, CMOs, CROs, and consultants) to help customers find the right partner
  • Lists of potential service providers based on technical capabilities, regulatory compliance, facilities, equipment, and more
  • Capability to rate companies and post comments on vendors
  • Functionality to post about projects and jobs specific to the pharmaceutical industry
  • Ability to make and share collections of vendors for each project
  • Easy to read vendor summary profiles, incorporating videos, images and the latest in Web 2.0 technologies

"In today's highly competitive marketplace, it's critical to be able to find quality partners that can reduce your costs of drug development and time-to-market," said Dr. Cary Queen, Co-Founder of Protein Design Labs. "The goBalto platform provides members with the transparency and ability to quickly identify and evaluate new partners via a rating system that includes rich vendor profiles."

"goBalto provides a great platform for showcasing our drug development and manufacturing capabilities to biotech and pharmaceutical companies around the globe," said Kiran-Mazumdar Shaw, Chairman and Managing Director of Biocon Limited. "The goBalto partnering website provides us with a highly cost-effective channel to reach our target customers compared to traditional options such as industry conferences and advertising."

According to market research company Kalorama, the market for contract manufacturing of prescription drugs exceeded $30 billion last year, a 10% increase over the previous year. "The sheer numbers of biologics in the pipeline are driving drug makers to outsource specialized production rather than build new plants," according to Kalorama.

"Most existing sites are "one-way" distributors of content from the publisher to the user," said Mr. Chung. "But users today are seeking a more collaborative platform. We're not only improving transparency, but incorporating the latest in Web social media tools to enable users to share their collective experiences on topics ranging from vendors to regions in which to conduct trials."

For further information, please visit:
http://www.gobalto.com

About Jae Chung, Founder and CEO
Jae Chung founded goBalto in October 2008. Prior to goBalto, he co-founded Celltrion, a contract biopharmaceutical group in Asia. As Celltrion's vice president of business development, he secured deals with Bristol-Myers Squibb and CSL, and has been credited with landing the largest biomanufacturing supply agreement in Asia to date. Before starting Celltrion in 2002, he was the co-founder of the venture capital firm, J. Stephen & Company Ventures, and a strategy consultant at McKinsey and Company.

About goBalto
goBalto is a dedicated online drug development partnering site for the pharmaceutical and drug manufacturing industry. Users can identify, evaluate, and manage drug-development partners from around the world. Incorporating the latest in Web 2.0 technologies, goBalto's platform enables users to distinguish their offerings by adding logos, images, videos, customer testimonials and post referrals from members. More than 7,000 service providers are currently listed.

Most Popular Now

Pfizer and BioNTech receive positive CHMP opinion …

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced a booster dose of their Omicron BA.4/BA.5-adapted bivalent COVID-19 vaccine (COMIRNATY® Original/Omicron ...

Vividion Therapeutics names Jenna Goldberg as Chie…

Vividion Therapeutics, Inc., a biopharmaceutical company utilizing novel discovery technologies to unlock high value, traditionally undruggable targets with precision the...

Bayer with continued strong performance

The Bayer Group maintained its strong business performance across all three divisions in the third quarter. "Despite rising inflation and global supply chain problems, we...

Sanofi and GSK's next-generation COVID-19 booster …

After the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion for VidPrevtyn® Beta, the vaccine was approved by t...

GSK announces positive Phase IIa study results for…

GSK plc (LSE/NYSE: GSK) announced positive results from a Phase IIa study demonstrating that GSK3036656, a first-in-class investigational antitubercular agent, was well t...

Sugar molecules as a target in cancer therapy

Cancer cells use sugar molecules on their surface to disable attacks by the body's immune system. Researchers at the University of Basel now report on how this mechanism ...

COVID vaccination improves effectiveness of cancer…

Patients with nasopharyngeal cancer are often treated with drugs that activate their immune system against the tumor. Until now, it was feared that vaccination against Co...

Making melanoma immortal: Pitt scientists discover…

Scientists at the University of Pittsburgh School of Medicine have discovered the missing puzzle piece in the mystery of how melanoma tumors control their mortality. I...

Unusual type of antibody shows ultrapotent activit…

An unusual type of antibody that even at miniscule levels neutralizes the Zika virus and renders the virus infection undetectable in preclinical models has been identifie...

New drug shows promise for fighting both COVID-19 …

While vaccination can provide life-saving protection against COVID-19, scientists are still searching for ways to treat severe infections, including in people who cannot ...

Machine learning can help predict patient response…

Predicting which patients will respond well to treatment is a quandary that has plagued the field of cancer immunotherapy for more than four decades. Now, researchers at ...

Study reveals vaccine confidence declined consider…

A new study suggests that, despite the success of the COVID-19 vaccination campaigns, vaccine confidence has declined significantly since the start of the pandemic. Re...